NCT07073287 Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients
| NCT ID | NCT07073287 |
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | Universidade Federal de Pernambuco |
| Condition | Stroke Rehabilitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.
This trial targets 30 participants in total. It began in 2024-05-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this clinical trial is to determine if cerebello-spinal direct current stimulation (csDCS) is effective in treating gait disorders in individuals with chronic stroke. Additionally, the trial seeks to evaluate the safety of this technique. The primary objectives include: Investigating whether cerebello-spinal direct current stimulation improves gait and functional mobility in participants with chronic stroke. Assessing any potential side effects associated with the method. Researchers will conduct a comparative analysis between cerebello-spinal direct current stimulation and a sham procedure (which mimics the stimulation without any actual effect) to assess its effectiveness in addressing gait disorders and enhancing mobility. Participants in the trial will: Undergo cerebello-spinal direct current stimulation combined with treadmill training or a sham procedure with treadmill training daily over a two-week period.
Eligibility Criteria
Inclusion Criteria: * Confirmation of Stroke by digital or physical imaging or medical report * Gait impairment * Stroke with at least 6 months after ictus Exclusion Criteria: * Metallic implants in spinal cord * Major orthopedic/rheumatological disorders * Inability of verbal or non-verbal communication
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07073287 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Stroke Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07073287 trial and what does that mean for participants?
Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.
Is NCT07073287 currently recruiting?
Yes, NCT07073287 is actively recruiting participants. Contact the research team at gmelodaniel@gmail.com for enrollment information.
Where is the NCT07073287 trial being conducted?
This trial is being conducted at João Pessoa, Brazil, Recife, Brazil, Rio de Janeiro, Brazil.
Who is sponsoring the NCT07073287 clinical trial?
NCT07073287 is sponsored by Universidade Federal de Pernambuco. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.